Sun Pharmaceutical Industries Ltd.

Sun Pharmaceuticals is currently trading at Rs. 713.50, up by 13.85 points or 1.98% from its previous closing of Rs. 699.65 on the BSE.

The scrip opened at Rs. 700.00 and has touched a high and low of Rs. 715.75 and Rs. 700.00 respectively. So far 24,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 775.90 on 20-Dec-2012 and a 52 week low of Rs. 512.50 on 24-Jan-2012.

Last one week high and low of the scrip stood at Rs. 739.95 and Rs. 694.20 respectively. The current market cap of the company is Rs. 73,886 crore.

The promoters holding in the company stood at 63.68% while Institutions and Non-Institutions held 25.90% and 10.42% respectively.

Sun Pharmaceutical Industries’ subsidiary - Caraco Pharmaceutical Laboratories has completed tender offer to acquire Dusa Pharmaceuticals for $8.00 per share, net to the seller thereof in cash, without interest thereon and less any applicable withholding taxes. As per the company, after the tender offer's expiration, 2,09,46,624 shares of common stock of Dusa had been validly tendered, representing nearly 82.4% of the outstanding shares of Dusa.

Caraco Pharmaceutical will move forward with a “short-form” merger under New Jersey law after exercising its top-up option under the merger agreement, and DUSA will become a wholly owned subsidiary of the company. Following the merger, DUSA's shares will cease to be traded on The NASDAQ Global Market.